Abstract Details
|
Prasanna Venkatesan Eswaradass, MD
(University of Kansas Health System)
PRESENTER |
Dr. Eswaradass has nothing to disclose. |
| Michael D. Hill, MD (University of Calgary) | Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular. |
| Richard H. Swartz, BSc MD PhD FRCPC (Sunnybrook Health Sciences Centre) | The institution of Dr. Swartz has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Swartz has received research support from Ontario Brain Institute. |
| No disclosure on file | |
| No disclosure on file |